Impaired cyclin D3 protein degradation contributes to trastuzumab resistance in HER2 positive breast cancer
Crossref DOI link: https://doi.org/10.1007/s12032-024-02535-x
Published Online: 2024-11-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, Zhuo
Lu, Haiqi
Zhong, Yiming
Feng, Lifeng
Jin, Hongchuan
Wang, Xian
Text and Data Mining valid from 2024-11-02
Version of Record valid from 2024-11-02
Article History
Received: 26 August 2024
Accepted: 5 October 2024
First Online: 2 November 2024
Declarations
:
: No potential conflicts of interest were disclosed.